Report Categories
View AllRecent Articles
View All
TOL Toll Brothers notches modest Q1 2026 EPS beat shares drop 162 as investors take a cautious stance
Nike Inc NKE PostQ3 FY2026 Earnings Underperformance and NearTerm Headwinds Signal Bearish Trajectory
The recurring revenue story behind Synopsys SNPS SNPS Synopsys Q1 2026 Earnings Beat Estimates by 4
Merck Co Inc MRK Implications of Partner AstraZenecas Q1 2026 Earnings Beat for Oncology Portfolio Trajectory